ID: ALA4526969

Max Phase: Preclinical

Molecular Formula: C47H51N5O7

Molecular Weight: 797.95

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c3c1O[C@H]1/C(=N\OCC(=O)NCCNC(=O)CCCCCn4cc(C(=O)c5cccc6ccccc56)c5ccccc54)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314

Standard InChI:  InChI=1S/C47H51N5O7/c1-51-26-22-46-42-31-18-19-38(57-2)44(42)59-45(46)36(20-21-47(46,56)39(51)27-31)50-58-29-41(54)49-24-23-48-40(53)17-4-3-9-25-52-28-35(33-14-7-8-16-37(33)52)43(55)34-15-10-12-30-11-5-6-13-32(30)34/h5-8,10-16,18-19,28,39,45,56H,3-4,9,17,20-27,29H2,1-2H3,(H,48,53)(H,49,54)/b50-36-/t39-,45+,46+,47-/m1/s1

Standard InChI Key:  RBSMMLLQHYGYIU-GPGFJTOFSA-N

Associated Targets(non-human)

Cannabinoid receptor 174 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mu opioid receptor 6060 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Delta opioid receptor 3911 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Kappa opioid receptor 4577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 797.95Molecular Weight (Monoisotopic): 797.3788AlogP: 5.68#Rotatable Bonds: 15
Polar Surface Area: 143.72Molecular Species: BASEHBA: 10HBD: 3
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 13.53CX Basic pKa: 8.99CX LogP: 5.20CX LogD: 3.60
Aromatic Rings: 5Heavy Atoms: 59QED Weighted: 0.07Np Likeness Score: -0.01

References

1. Dvorácskó S, Keresztes A, Mollica A, Stefanucci A, Macedonio G, Pieretti S, Zádor F, Walter FR, Deli MA, Kékesi G, Bánki L, Tuboly G, Horváth G, Tömböly C..  (2019)  Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors.,  178  [PMID:31220675] [10.1016/j.ejmech.2019.05.037]

Source